Showing posts with label general toxicology. Show all posts
Showing posts with label general toxicology. Show all posts

Saturday, 10 February 2018

Series 7: Multiple Choice Questions and fill in blanks TOXICOLOGY Question and Answer bank by Dr Pawan K (PK) Gupta


INTRODUCTION
TOXICOLOGY Question and Answer bank is aimed to make the study of toxicology simple and understandable ---------------------

Series 7: Multiple Choice Questions and fill in blanks

Multiple Choice Questions

Exercises
Q. 1. Examples of significant concentrations of a toxicant in a tissue that is not a target organ include all of the following except-----------.
a) lead in bone
b) DDT in adipose tissue
c) paraquat in lung
d) TCDD in adipose tissue
Q. 2. the ability of a chemical to cause acute skin and eye irritation is usually evaluated in a ------
a) rabbit
b) rat
c) mouse
d) dog
Q. 3.  before a potential pharmaceutical compound can be given to humans .-------.
a) an NDA must be filed with the FDA
b) an IND must be filled with the FDA
c) acute toxicity studies on 4 species must be conducted
d) a 2-year dog carcinogenicity study must be completed
Q. 4.  phase 1 clinical trials are conducted to determine all of the following except ---
a) pharmacokinetics
b) safety
c) rare adverse effects
d) preliminary efficacy
Q. 5. MTD stands for ------------------
a) minimum tolerated dose
b)maximum total dose
c) maximum tolerated dose
d) maximum threshold dose
Q. 6. the acute toxicity study in animals provides ------
a) an appropriate lethal dose
b) information on target organs
c) information on dose selection for long-term studies
d)all of the above
Q. 7. a subacute toxicity study in rats usually lasts ------.
a) 3 days
b)14 days
c) 3 months
d) 6 months
Q. 8. the period of organogenesis in rats is ---.
a) day 3-10
b) day 7-17
c)  day 12-25
d) day 17-56
Q. 9.  a dose of investigational drug that suppresses body weight gain slightly in a 90-day animal study is defined by some regulatory agencies to be-------.
a) LOAEL
b) NOAEL
c)MTD
d) reference dose
Q. 10. a subchronic animal study required by the FDA will usually include-----
a) two species (usually one rodent and one nonrodents)
b) both genders
c) at least three doses (low, intermediate, and high)
d) all of the above

Q.11 A dose of a compound A is toxic to animals in vivo. Another chemical B is not toxic when given at doses several orders of magnitude higher but when the two are given together the toxic response is greater than that of the given dose of A alone.
a) antagonism
b) synergism
c) additivity
d) potentiation
e) none of the above
Q.12 Which information may be gained from an acute toxicity study
a) no effect level
b) LD50 
c) therapeutic index
d) target organ
e) all of the above
Q.13The therapeutic index is usually defined as
a) TD50 / LD50 
b) ED50 / LD50 
c) LD50   / ED50
d) ED50  / TD50
e) LD50   / ED50
Q.14 1000 ppm is equivalent to 1%
a) True
b) False

Answers
1. c;      2. a;      3. b ;     4.c ;      5.c ;      6.d ;      7.b ;     8.b ;      9.c ;      10. d; 11. d; 12. e; 13. c ; 14. b.

Fill in blanks

Q. 1. The branch of science which deals with the harmful effects of physical and chemical agents of human and animal life is ------------------------------------
Q. 2. In the term toxicology, the word ‘toxicon’ (Greek) means --------------------
Q. 3. The branch of toxicology, which deals with diagnosis, treatment and management of toxic substances, is known as -----------------------------------
Q. 4. The development and interpretation of mandatory toxicology testing programs is addressed by -------------------------------------------
Q. 5 Investigating and controlling the toxic effects of various substances on the community is dealt by ----------------------.
Q. 6. The study of toxicity produced by subsances of plant, animal and microbial origin is termed as -------------
Q. 7. A foreign chemical substance, which is not normally produced in the body or forms a part of the food, is known as --------------------.
Q. 8. The source of adverse effect/ damage is known as ----------------------
Q. 9. The likelyhood/probability of adverse effect upon exposure to a hazard is known as --------------------.
Q. 10. The statement, “all substances are poisons; the dose differentiates poison from a remedy” is associate with -------------------------.

Answers
1.TOXICOLOGY; 2. POISON; 3.CLINICA L TOXICOLOGY; 4. REGULATORY TOX COLOGY; 5 TOXICOVIGILANCE; 6. TOXINOLOGY; 7. XENOIOTIC; 8 HAZARD. (eg: Water containing Fluoride; Here fluoride is the hazard and fluorosis is the adverse effect. Hazard is independent of dose or exposure i.e., it is present whether someone drinks the water or not).
9. RISK. (eg: While drinking water containing fluoride, the chances of getting fluorosis is called risk. Risk can range from 0 to 100% depending on dose and exposure i.e., one should be exposed to a hazard to calculate the risk); 10. PARACELSUS

Exercises
Q. 1 The scientist referred to as ‘Father of Toxicology’ is ------------------------
Q. 2.  DDT (Dichlorodiphenytrichloro ethane) which is used to control malaria and typus was discovered by ----------------------------
Q. 3. The person who is known as ‘Father of Nerve Agents’ is ------------------------------
Q. 4. The author of the book ‘Silent Spring’ in which the detrimental effect of DDT and other pesticides on environment –particularly on birds was document is -------------------------. 
Q. 5. Bhopal gas tragedy, which is considered to be the world’s worst industrial disaster, was caused due to the leakage of------------------------------------ from Union Carbide fertilizer company.
Q. 6. Use of thalidomide in pregnant women for treating women for treating morning sickness led to -------------------------condition in the infants.
Q. 7. If the action of one substance opposes or neutralizes the effect of another substance, the relationship is referred to as -------------------------..
Q. 8. Rodents are preferred for oral toxicity testing as they lack ------------------ reflex.
Q. 9. Maximum acceptable/ permitted amount of a drug present in feed and foods is known as ----------------------------------------------------------------------.
Q. 10. The highest dose of a compound, which produces adverse effects but no mortality is called -----------------------------------------------------------------------.
Answers
1. M.J.B. Orfila; 2. Pau Muller; 3 GERHARD SCHRADER; 4. RACHEL CARSON;5. METHYL-ISOCYANATE (MIC); 6. PHOCOMELIA; ;7. ANTAGONISM (All antidotes have antagonistic relationship with their respective toxicants) have antagonistic relationship with the irrespective toxicants); 8. VOMITION; 9 MAXIMUM RESIDUE LEVEL (MRL). (For pesticides – MAXIMUM RESIDUE LIMIT); 10 MAXIMUM TOLERATED DOSE {(MTD),  MTD is also referred to as LD0 (Zero) as it will cause adverse effects but no mortality)}.

Exercise
Q.1. If the period of exposure of a toxicant is more than 3 months, the type of study is termed as ---------------------.
Q. 2. The type of toxicity which results due to progressive accumulation of a toxicant in the body is known as ------------------------------.
Q. 3. The amount of toxicant in food and water, which can be consumed daily over a life time without any significant health risk, is called as ------------------------------------------.
Q. 4 Unlawful or criminal killing of animals through administration of poisonsis known as -----------------------
Q. 5. Unintentional addition of toxicants and contaminants in feed  and water is known as ----------------------.
Q. 6. Man -made sources of toxicants are referred to as ------------------------ sources.
Q. 7. Genetically determined abnormal reactivity of an individual to a chemical is known as----------------------------..
Q. 8. Failure to elicit a response to an ordinary dose of a substance due prior usage is known as --------------------------.
Q. 9. The beneficial effects of toxic substances at low doses are known as-----------------.
Q. 10. In the event of irreparable injury, the cell undergoes a process of programmed cell death known as ----------------------------.
Q. 11 A substance is classified as extremely toxic if the lethal dose (LD) is LESS THAN ------------- and as practically non-toxic if the LD is ------------.
Q. 12. The ability of a substance to induce cancer is known as ------------------.    

Answers
1. CHRONIC TOXICITY; 2. CUMULATIVE TOXICITY(Several toxicants such as heavy metals, alcohol, DDT etc cause cumulative toxicity.); 3. ACCEPTABLE DAILY INTAKE (ADI); 4. MALICIOUS POISONING; 5. ACCIDENTAL POISONING; 6. ANTHROPOGENIC; 7. IDIOCYNCARY; 8. TOLERANCE(Tolerance is generally caused due to the induction of metabolizing enzymes in liver. However, in case of chronic alcoholism, pseudo-tolerance is observed, due to thickened GIT mucosa, which reduces absorption);

9. HORMESIS; 10. APOPTOSIS(Apoptosis is also involved in number of physiological process such as embryogenesis, ageing, cancer prevention etc); 11. 1mg/kg, 5 to 15 g/kg(It should be remembered that more the LD of a compound, less is its toxicity); 12. CARCINOGENESIS

FURTHER READING

Gupta PK (2018) Illustrative Toxicology with Question bank. 1st Edition. Elsevier, USA

Gupta PK (2016) Fundamentals of Toxicology: Essential concepts and applications. 1st Edition. ISBN-9780128054260, pp 438, BSP/Elsevier, USA

The Merck Veterinary Manual (2016). Chapter “Herbicide Poisoning” by PK GUPTA 11th edition, Merck & Co. Inc Whitehouse Station, NJ, USA  2969-99

The Merck Veterinary Manual (2016). Chapter “Pentachlorophenol Poisoning” by PK GUPTA 11th edition, Merck & Co. Inc Whitehouse Station, NJ, USA  pp 3052-53

Gupta PK (2016) Essential Concepts in Toxicology. Published by PharmaMed Press (A unit of BSP Books Pvt. Ltd), Hyderabad, India pp 362.

Gupta PK (2010) Modern Toxicology, Basis of organ and reproduction toxicity. Vol 1. Published by Pharma  Med Press (A unit of BSP Books Pvt. Ltd). Hyderabad, India pp 1-460.

Gupta PK (2010) Modern Toxicology, Adverse effects of xenobiotics. Vol 2, Published by PharmaMed Press (A unit of BSP Books Pvt. Ltd). Hyderabad, India pp 1-460.

Gupta PK (2010) Modern Toxicology, Immuno and clinicsal toxicology Vol 3. Published by PharmaMed Press (A unit of BSP Books Pvt. Ltd). Hyderabad, India pp 1-340.


                                                                                                                     To be cont'd

Wednesday, 7 February 2018

Series 5: -Risk Assessment- TOXICOLOGY Question and Answer bank by Dr Pawan K (PK) Gupta

Series 5: TOXICOLOGY Question and Answer bank -Risk Assessment

Cont’d from series 4
Q. Define risk
Risk is defined as the probability of an adverse outcome based upon the exposure and potency of the hazardous agent(s).
Q. Define safety
Means practical certainty that injury will not result from use of a substance under specified condition of quantity and manner of use.
Q. Define benefit-to-risk-ratio
This implies that even a toxic agent may warrant use if its benefits for a significant number of people are much greater than the dangers,
Q. Describe briefly risk assessment
Risk assessment is a quantitative assessment of the probability of deleterious effects under given exposure conditions. It requires an integration of both qualitative as well as quantitative scientific information. For example, qualitative information about the overall evidence and nature of the endpoints, and hazards are integrated with quantitative assessment of the exposures, host susceptibility factors, and the magnitude of the hazard. A description of the uncertainties and variability in the estimates is a significant part of risk characterization and an essential component of risk assessment.
Q. Define hazard
It is the qualitative description of the adverse effect arising from a particular chemical or physical agent with no regard to dose or exposure. The term hazard is related to the risk, but it mainly expresses likelihood or probability of danger, irrespective of dose or exposure.
Or
A property or set of properties of the chemical substance that may cause an adverse health or ecological effect provided if there is an exposure at a sufficient level.
Q. Define acceptable risk
It is the probability of suffering a disease or injury during exposure to a substance, which is considered to be small but acceptable to the individual.
Q. Define acceptable exposure
It is the unintentional contact with a chemical or physical agent that results in the harmful effect.
Q. Define margin of exposure (MOE)
Margin of exposure is defined as the ratio of the no-observed adverse-effect-level (NOAEL) for the critical effect to the theoretical, predicted, or estimated exposure dose or concentration.
Q. Define threshold limit values (TLV)
The TLV refers to the airborne concentration of a substance to which it is believed a worker can be exposed day after day for a working lifetime without adverse effects. These values are expressed as time weight concentration for 7 to 8 hr work day and for 40 week.
Q. Define No Observed Effect Level / Concentration (NOEL/ NOEC)
NOEL/ NOEC is the highest dose level/concentration of a substance that under defined conditions of exposure causes no effect (alteration) on morphology, functional capacity, growth, development or life span of the test animals.
Q. Define No Observed Adverse Effect Level / Concentration (NOAEL / NOAEC).
NOAEL/ NOAEC is the highest dose level/concentration of a substance that under defined conditions of exposure causes no observable/detectable adverse effect (alteration) on morphology, functional capacity, growth, development or life span of the test animals. NOAEL / NOAEC is a variant of NOEL/ NOEC that specifies only that the effect in question is adverse.
Q. Define Lowest Observed Adverse Effect Level / Concentration (LOAEL/ LOAEC)
LOAEL / LOAEC is the highest exposure level/dose level/concentration of a substance under defined conditions of exposure an observable/detectable effect (alteration) on morphology, functional capacity, growth, development or life span of the test animals is observed.
Q. Define Reference Dose/Concentration (RfD/RfC): For non-cancerous effects oral intake (RfD) or an inhalation reference concentration (RfC) for airborne materials is calculated using the NOAEL or LOAEL as a starting point. These values are developed from experimentally determined NOAEL or LOAEL.

Preliminary evaluation of risk assessment

Q. Describe briefly requirement of data for preliminary evaluation of risk assessment in human health?
The type of data required for preliminary evaluation is summarized in THE FOLLOWING Table

Table: Data required for preliminary evaluation of risk assessment in human health

Data required
Quality data
Physiochemical processes
Observed effects on humans
Toxicity
Derived from animal studies
Release /transport / uptake
Applicable to expected dosage
Chemical physical interaction
Most current to support specific conclusions


Basic elements of risk assessment

Q. What are the basic elements involved in the process of risk assessment?
Four steps used in risk analysis include:
a) Hazard identification
b) Dose response evaluation
c) Exposure assessment
d) Risk characterization.
Explanation: The initial step is hazard identification, which identifies the chemical that present a risk to human health. This is a qualitative step, which involves a thorough evaluation of current scientific evidence, including animal studies, human studies, epidemiological studies and cellular studies. If a chemical is identified as a potential hazard to human health, the process continues.
The second step of risk analysis, is the dose-response evaluation, which is a quantitative step. This step measures the magnitude of the response at different doses. If available, human studies showing the potency of the agent, or its ability to produce negative health effects in humans, are also assessed.
The next step, is the exposure assessment. This step seeks to estimate people's level of exposure. Exposure refers to the amount of a substance in the environment, and such an estimation include the length of exposure, duration of exposure and route of exposure, among other considerations. The difference between the actual dose, or level of a substance taken in, and the amount of the substance measured (exposure) is included in this assessment. This assessment must also quantify various properties of a substance-e.g. volatility, as well as the group exposed and whether the exposure is continuous, intermittent, short term, long term or chronic.
The final step is risk characterization. This step uses all of the previously gathered information through the first three steps, and creates a picture of risk that describes its likelihood, severity and consequences. This characterization includes an estimate of the negative effects-e.g. deaths or cancer cases per 100,000 people. The final step also takes into account any limitations and or uncertainties that were involved in creating the estimate.  

Hazard identification

Q. Name four steps involved in hazard identification used for risk assessment process.
     Hazard identification involves the following four steps
                         (a)     Epidemiology
                         (b)     Animal studies
                          (c)     Short term assays
                         (d)     Structure activity relationship

Dose response assessment

Q. Name three steps involved in dose response assessment used for risk assessment process.
     Dose response assessment involves the following three steps
                         (a)     Quantitative toxicity information collected
                         (b)     Dose-response relationship established
                          (c)     Extrapolation of animal data to human

Exposure assessment

Q. Name three steps involved in exposure assessment used for risk assessment process.
     Exposure assessment involves the following three steps
                         (a)     identification of exposed populations
                         (b)     identification of routes of exposure
                          (c)     identification of degree of exposure

Risk characterization

Q. Name three steps involved in risk characterization used for risk assessment process
     Risk characterization involves the following three steps
                         (a)     Estimation of the potential for adverse health effects to occur
                         (b)     Evaluation of uncertainty
                          (c)     Risk information summarized
Q. Discuss at least three limitations inherent in risk analysis.
Limitations to risk analysis include:
(a)    Uncertainty of effect
(b)    Variability of exposure
(c)      Possibility of multiple exposures
Explanation: Often, too little is known about any substance to provide any real assurance. Despite laboratory testing and careful risk analysis, uncertainty will remain. Interpersonal variability may also strongly affect a specific individual's risks, as a general overview may not identify people who may be more sensitive to exposures than others, and thus may have a higher "safe" dose. Multiple-exposures are difficult to study, although they certainly exist in the real world. In addition, any additive effects are ignored, which may heighten the risk and which are sure to occur outside of the laboratory. However, despite its limitations, risk analysis is still an important tool to explore and understand risks in the modern world.

 Establishment of an acceptable reference dose (RfD)


Q. How an acceptable reference dose (RfD) is established for risk assessment?
     Acceptable reference dose (RfD) is established by the following relationship.
                                      RfD= NOAEL/(UF ×MF)
                                      ADI = NOAEL/(UF ×MF)
     Where the uncertainty factor (UF) is typically equal to 100 and modifying factor (MF).
     For cancer end points, the only strictly safe exposure level is at zero dose, although for very small doses the risk is extremely low and is not considered significant.
Explanation: Approaches for characterizing dose-response relationships include identification of effect levels such as LD50 (dose producing 50 % lethality), LC50  (concentration producing 50 % lethality), ED10 (dose producing 10% response), as well as NOAELs. NOAELs have traditionally served as the basis for risk assessment calculations, such as reference doses or acceptable daily intake (ADI) values. Reference doses (RfDs) or concentrations (RfCs) are estimates of a daily exposure to an agent that is assumed to be without adverse health impact in humans. The ADIs are used by WHO for pesticides and food additives to define “the daily intake of chemical, which during an entire lifetime appears to be without appreciable risk on the basis of all known facts at that time”. Reference doses and ADI values typically are calculated from NOAEL values by dividing uncertainty (UF) and / or modifying factors (MF). Tolerable daily intakes (TDI) can be used to describe intakes for chemicals that are not “acceptable” but are “tolerable” as they are below levels thought to cause adverse health effects. These are calculated in a manner similar to ADI. In principle, dividing by the uncertainty factors allows for interspecies (animal-to-human) and intra species (human-to-human) variability with default values of 10 each. An additional uncertainty factor is used to account for experimental inadequacies—for example, to extrapolate from short exposure - duration studies to a situation more relevant for chronic study or to account for inadequate numbers of animals or other experimental limitations. If only a LOAEL value is available, then an additional 10-fold factor commonly is used to arrive at a value more comparable to a NOAEL. Traditionally, a safety factor of 100 is used for RfD calculations to extrapolate from a well-conducted animal bioassay (10-fold factor animal to human) and to account for human variability in response (10-fold factor human-to-human variability).
     Assumption is made that exposure below a certain level, the NOAEL, will have no adverse health consequences. An acceptable reference dose, RfD, is then established.

To be cont’d